Looks like buyers have to step up.
In this thread, I commented on the value of CU6’s Priority Review’s. You’ll see the post if you scroll up.
Do you have any thoughts on CU6 selling these, as per my comments?
Ann: Positive Guidance from FDA on Phase 3 Prostate Cancer Trial, page-47
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.16 |
Change
-0.040(0.77%) |
Mkt cap ! $1.614B | |||
| Open | High | Low | Value | Volume |
| $5.24 | $5.46 | $5.09 | $3.057M | 584.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 3557 | $5.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.18 | 3728 | 11 |
View Market Depth
| Last trade - 13.57pm 04/07/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |